IGF-1 DES
Molecular Profile
Compound
IGF-1 DES
Also known as
des(1-3)IGF-1
CAS number
112603-35-7
Molecular formula
C319H495N91O96S7
Molecular weight
7365.40 g/mol
Purity
greater than 99 percent
Physical form
Lyophilized powder
Synthesis route
Solid-phase peptide synthesis
What IGF-1 DES is, structurally
IGF-1 DES is the des(1-3) form of IGF-1: the parent sequence with its first three residues removed, leaving sixty-seven where the parent has seventy.
The stated mass supports that description rather than merely accompanying it. Glycine, proline and glutamate contribute 283.28 units as residues, and adding that to the quoted 7365.40 gives 7648.68, which is the published mass of the parent. The specification is internally consistent, and the two substances are separated by that difference. Anything close to 7649 is the parent, not this material.
The seven sulfurs are the more consequential feature, and they are not interchangeable. Six belong to cysteines paired into three disulfide bonds; the seventh is a methionine thioether. Three disulfides across sixty-seven residues is a densely cross-linked molecule, and almost everything below follows from that.
The immediate consequence is that reducing agents must be kept away from this material entirely. Dithiothreitol, TCEP and 2-mercaptoethanol will break the cross-links, and a reduced molecule is a different substance from the one in the vial. Where many peptides tolerate or even benefit from a reducing agent, here it is destructive rather than merely unnecessary.
The second consequence is subtler and easier to cause by accident. Disulfide exchange is catalysed by thiolate, which forms as pH rises, so an alkaline buffer allows the three bonds to reshuffle into wrong pairings. Scrambled material has the same molecular formula and the same mass as correctly folded material, so this is a failure that ordinary mass spectrometry does not see.
Reconstitution and handling
Sterile water is the default solvent. Where a buffer is needed, keep it at or below neutral pH: mildly acidic to neutral conditions suppress the thiolate-mediated exchange described above, while alkaline conditions promote it. This is the reverse of the advice that suits an acidic peptide with no cysteines, and the difference is worth being deliberate about.
Add diluent down the inside wall of the vial, swirl gently, and let the solution clarify. Vortexing introduces foam without dissolving anything faster, and on a cross-linked molecule of this size the mechanical stress is better avoided.
Do not add a reducing agent, for the reason above.
Adsorptive loss deserves allowance at low concentration, with low-protein-binding tubes reducing it. At seven and a half kilodaltons this is a large peptide, and surface losses matter more than they would for a short one.
This is laboratory preparation chemistry, not dosing, administration, or protocol guidance of any kind.
Storage and stability
Store the lyophilized powder at -20 degrees C, sealed, desiccated and protected from light, and let a cold vial warm before opening. Reconstituted, hold at 2 to 8 degrees C, or aliquot and freeze rather than thawing repeatedly. Repeated freeze-thaw is a greater liability for a folded, cross-linked molecule than for a short linear peptide, because the damage is structural rather than only chemical.
Two degradation routes are named by the formula. The single methionine oxidises to the sulfoxide, adding sixteen units, which mass spectrometry resolves cleanly at this size. The three disulfides can scramble, which mass spectrometry does not resolve at all, since the rearrangement is isomeric.
Cold, dry, near-neutral storage limits both. Air exposure matters here in a way it does not for a sulfur-free peptide.
These are storage conditions for the material, not dosing or administration guidance.
How IGF-1 DES is tested
Reversed-phase HPLC establishes chromatographic purity as area percent. The most useful check on this molecule is comparative rather than absolute: running the material alongside a deliberately reduced aliquot separates correctly folded material from reduced or scrambled forms, which differ in retention even when they do not differ in mass.
Area percent is a chromatographic measure and not peptide content by weight. Solid-phase synthesis delivers a salt, and residual trifluoroacetate is its own impurity class.
Mass spectrometry confirms identity against 7365.40. Three checks are worth naming. A result near 7649 indicates the parent rather than this material. A result six units above the expected mass indicates fully reduced material, since each disulfide formed removes two hydrogens. A result sixteen units high indicates methionine sulfoxide. What mass spectrometry cannot report is disulfide scrambling, and that gap is the reason the comparative chromatographic check earns its place.
These describe general methodology, not a claim about any particular batch.
Handling FAQ
Can a reducing agent be used to help this dissolve? No. The molecule holds three disulfide bonds, and dithiothreitol, TCEP or 2-mercaptoethanol will break them. Reduced material is a different substance from what the vial contains, and the change is not reversible by simply removing the reagent.
How is this distinguished from ordinary IGF-1? By mass. The parent is seventy residues at about 7649, and this is sixty-seven at 7365.40. The difference of 283.28 is exactly glycine, proline and glutamate as residues, which is the truncation that defines the des(1-3) form.
Full specifications for IGF-1 DES.
IGF-1 DES is available as a research compound, HPLC-verified with a batch-specific COA.
For mechanism and published findings, see the research article.
More Handling References
GHRP-2
What GHRP-2 is chemically and how to handle it in the lab: hexapeptide structure, reconstitution, storage, stability, and verification.
Read ReferenceGHRP-6
What GHRP-6 is chemically and how to handle it in the lab: hexapeptide structure, reconstitution, storage, stability, and verification.
Read ReferenceHexarelin
What Hexarelin is chemically and how to handle it in the lab: hexapeptide structure, reconstitution, storage, stability, and verification.
Read ReferenceIGF-1 LR3
What IGF-1 LR3 is chemically and how to handle it in the lab: protein analogue structure, reconstitution, storage, stability, and verification.
Read ReferenceSermorelin (GRF 1-29)
What Sermorelin (GRF 1-29) is chemically and how to handle it in the lab: 29 residue peptide structure, reconstitution, storage, stability, and verification.
Read ReferenceTesamorelin
What Tesamorelin is chemically and how to handle it in the lab: 44 residue peptide structure, reconstitution, storage, stability, and verification.
Read Reference


